Advaxis Stock Price (NASDAQ:ADXS)

Add to My Stocks
$8.46 $0.11 (1.28%) ADXS stock closing price Feb 24, 2017 (Closing)
YOUR DAILY UPDATE ON
ADXS
Advaxis
24 FEB 2017
amigobulls logo
ADXS hand_up
ADXS vs S&P 500
Closing Price: Feb 24, 2017
ADXS
$8.46 ( -1.28%)
S&P 500
2367.3 ( 0.15%)
ADXS
52 Week Price Range
1 Year Return: 52.76%
Q4 Growth*
Poor
Profitable ?
No
net image
2016 Q4 Net Loss
-1843.9%
Pays Dividend ?
Yes
dividend
12 Months Dividend
  : $0
Dividend Yield
  : -99900%
home image
Rating
ADXS POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Advaxis Snapshot Video

12 5 2

ADXS Stock Details

Prev Close* : $8.57
Market Cap:
$339.43M
Day Low: $8.38
52 Week Low: $5.36
Open: $8.44
Volume: 394502
Day High: $8.6
52 Week High: $16.30
Dividend:
N/A

Latest Stock Market News

Latest Articles

Advaxis News - From Partners

ADXS Stockcharts

View ADXS PE ratio, PS ratio stocks charts and compare with peers.
ADXS Chart
Note: Compare Advaxis stock price history with the index and industry peers.

Advaxis Financial Ratios

Asset Turnover
0.12
Receivables Turnover
4.82

ADXS Industry Peers

Company Price Change (%)
Ocata Therapeutics (OCAT)8.470 (0%)
Arna Pharma (ARNA)1.470.05 (3.52%)
Aratana Therapeutics (PETX)6.550.04 (0.61%)
Astrazeneca (AZN)29.350.16 (0.54%)
Aduro Biotech (ADRO)11.350.2 (1.79%)
Inovio Pharma (INO)6.680.22 (3.19%)
Agenus (AGEN)3.850.02 (0.52%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Incyte (INCY)131.219.26 (7.59%)
Sarepta Therapeutics (SRPT)32.021.87 (6.2%)
Stemline Therapeutics (STML)6.850.4 (6.2%)
Bluebird Bio (BLUE)823.7 (4.73%)
Puma Biotech (PBYI)36.21.5 (4.32%)
Sangamo BioSciences (SGMO)40.15 (3.9%)
Epizyme (EPZM)12.150.45 (3.85%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017
CompanyPriceChange (%)
Achillion Pharma (ACHN)3.860.38 (8.96%)
Chromadex (CDXC)2.740.13 (4.53%)
Idera Pharma (IDRA)1.670.06 (3.47%)
Inovio Pharma (INO)6.680.22 (3.19%)
VIVUS (VVUS)1.140.03 (2.56%)
Ligand Pharma (LGND)100.382.46 (2.39%)
Compugen (CGEN)4.30.1 (2.27%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017

Advaxis Financial Statements

income statement20162015201420132012
Net Sales Or Revenues3.99M-1M--
Net Income-73.55M-47.03M-16.52M-19.98M-12.06M
Total Operating Expense80.48M48.67M20.53M14.69M12.32M
view Advaxis, Inc. income statement
balance sheet20162015201420132012
Total Assets169.04M119.6M23.37M23.58M3.81M
Total Liabilities49.74M4M2.74M5.58M9.77M
Shareholders Equity119.3M115.59M20.62M18M-5.96M
view Advaxis, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities39.85M1.02M-4.54M-0.27M5.87M
Net Cash From (Used By) Operating Activities-9.07M-24.13M-17.02M-8.71M-4.56M
Increase (Decrease) In Prop Plant And Equipment-3.22M-0.97M-0.02M-0.02M-0.09M
view Advaxis, Inc. cashflow statement

Advaxis Stock Message Board

Advaxis stock price ended the last trading day at 8.46. Looking at Advaxis market capitalization, which currently stands at 343.85M, we can say that ADXS stock is a Small cap stock. Advaxis valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Advaxis is worth a lot, it will most likely be reflected in an inflated Advaxis stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 394502 shares were traded with a closing stock price of 8.46 as of 24 Feb, 2017, as can be seen from Advaxis stock quote. One can view Advaxis stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Advaxis stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.